Māori | Pacific | Non-Māori/non-Pacific | |
---|---|---|---|
N (%) | N (%) | N (%) | |
Total | 302 (100) | 70 (100) | 1427 (100) |
Age (years) | |||
20–35 | 10 (3.3) | 4 (5.7) | 25 (1.8) |
36–50 | 97 (32.1) | 37 (52.9) | 377 (26.4) |
51–65 | 137 (45.4) | 19 (27.1) | 589 (41.3) |
>65 | 58 (19.2) | 10 (14.3) | 436 (30.6) |
NZDep (quintiles) | |||
Q1 (least deprived) | 16 (5.3) | 5 (7.1) | 282 (19.8) |
Q2 | 31 (10.3) | 5 (7.1) | 265 (18.6) |
Q3 | 52 (17.2) | 9 (12.9) | 333 (23.4) |
Q4 | 73 (24.2) | 21 (30.0) | 325 (22.8) |
Q5 (most deprived) | 130 (43.1) | 30 (42.9) | 218 (15.3) |
Extent | |||
Local | 136 (52.5) | 28 (52.8) | 712 (56.7) |
Regional | 116 (44.8) | 23 (43.4) | 528 (42.0) |
Distant | 7 (2.7) | 2 (3.8) | 16 (1.3) |
Tumour size (mm) | |||
<10 mm | 34 (12.8) | 9 (15.8) | 308 (23.6) |
11–19 | 69 (25.9) | 16 (28.1) | 416 (31.9) |
20–29 | 105 (39.5) | 13 (22.8) | 325 (24.9) |
30+ | 58 (21.8) | 19 (33.3) | 255 (19.6) |
Diabetes | |||
Yes | 58 (19.2) | 12 (17.1) | 115 (8.1) |
No | 244 (80.8) | 58 (82.9) | 1,309 (91.9) |
Eligible for free screeninga | |||
% never screened | 5 % | 5 % | 12 % |
% tumours < 10 mm (p <0.001) | 14 % | 20 % | 26 % |
% localized stage (p <0.001) | 47 % | 40 % | 53 % |